CJC-1295 / Ipamorelin 5mg/5mg – Growth Hormone Secretagogue Research Blend
 
CJC-1295 / Ipamorelin is a high-purity peptide combination designed to investigate the dual-action stimulation of growth hormone pathways in advanced laboratory research settings.
This formulation pairs CJC-1295 (a Growth Hormone Releasing Hormone or GHRH analog) with Ipamorelin (a selective Growth Hormone Secretagogue Receptor or GHSR agonist). In experimental models, this synergistic blend is studied for its ability to mimic the natural pulsatile release of growth hormone by simultaneously stimulating the pituitary gland and inhibiting somatostatin. Researchers utilize this combination to analyze metabolic rate regulation, cellular repair mechanisms, and the modulation of lean muscle mass and fat metabolism.
 
Because CJC-1295 (without DAC) has a shorter half-life, this blend allows for the study of acute physiological responses and specific endocrine signaling patterns without the prolonged systemic exposure of long-acting analogs.
 
High purity (99.84% HPLC)
Dual-action formulation (5mg CJC-1295 / 5mg Ipamorelin)
Net Content: 5.96mg CJC-1295 / 5.68mg Ipamorelin
Identity confirmed via LC-MS analysis
 
For laboratory research use only. Not for human or veterinary consumption.
 
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.